Replies to post #19700 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[haysaw]

I think they are going to have to synthesize a more powerful compound, or combine anatabine with other drugs, treatments, supplements or remedies, to have a chance in biotech development. The stories of anatabine curing all kinds of ailments does not pass the smell test. The science and medical community most certainly wouldn't endorse or put much faith in such claims--it would be naive at best, career suicide at worst. There will be setbacks and progress with the future development, but the key will be the precision and abilities of the scientists, and the vision of mgmnt on how to position their drug/drugs commercially, especially in regards to viable combo/cocktail candidates. The key is synergy.

It's going to be a long road ahead, with lots of bumps, and of course, no guarantees of success. Until then, be sure to eat your fruits and vegetables.

[leifsmith]

Very significant. Thanks!

[bhp1rtp]

Nuke

I really like the last sentence in the abstract
___________________________________________________________

Anatabine shows potential at improving memory following TBI, mitigating against pathogenic neuroinflammation, and may have a long therapeutic window __________________________________________________________

It sounds like to me that the scientist now believes Anatabine will be effective even if its use is started 9 months after the repetitive mild TBI (r-mTBI). I think this is huge and could lead to more funding for studies and even a clinical trial. I am thinking NFL and Defense Department should be interested in this.